Novel Analgesics for the Treatment of Bone Cancer Pain

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43CA110524-01
Agency Tracking Number: CA110524
Amount: $109,305.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solitcitation Year: 2004
Solitcitation Topic Code: N/A
Solitcitation Number: PHS2004-2
Small Business Information
ST. CHARLES PHARMACEUTICALS
ST. CHARLES PHARMACEUTICALS, PO BOX 850616, NEW ORLEANS, LA, 70185
Duns: N/A
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 ANTHONY Vaccarino
 (504) 280-6771
 AVACCARI@STCHARLESPHARMA.COM
Business Contact
 KENNETH NARDUCY
Phone: () -
Email: KNARDUCY@MSN.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Pain is the most prevalent symptom in cancer patients, and bone metastasis is one of the most common sources of cancer-related pain. In the 3-step guidelines established by the World Health Organization (WHO) non-opioi

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government